Optimal timing of administration of hyperthermia in combined radioimmunotherapy

Cancer Biotherapy and Radiopharmaceuticals

Volumn 15, Issue 4, 2000, Pages 373-379

  Kinuya, S ^a   Yokoyama, K ^a   Hiramatsu, T ^a   Konishi, S ^a   Watanabe, N ^b   Shuke, N ^c   Aburano, T ^c   Bunko, H ^d   Michigishi, T ^a   Tonami, N ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; COLON CANCER; HUMAN; HYPERTHERMIA; MULTIMODALITY CANCER THERAPY; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIOIMMUNOTHERAPY; RADIOSENSITIVITY;

EID: 0033771640     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2000.15.373     Document Type: Article

References (33)

1. Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: Results of phase I trials
2. Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer
3. Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG
4. Effects of hyperthermia and iodine-131-labeled anticarcinoembryonic antigen monoclonal antibody on human tumor xenografts in nude mice
5. Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts
6. Phase I/II trial of combined 131I anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinoma
7. Combination radioimmunotherapy with local hyperthermia: Increased delivery of radioimmunoconjugate by vascular effect and its retention by increased antigen expression in colon cancer xenografts
8. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: Doxorubuicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type
9. Synergy of taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: Efficacy and toxicity in breast cancer xenografts
10. Addition of cisplatin improves efficacy of 131I-labeled monoclonal antibody 323/A3 in experimental human ovarian cancer
11. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil)
12. Efficacy, toxicity and mode of interaction of combination radioimmunotherapy with 5-fluorouracil in colon cancer xenografts
13. Enhanced delivery of a monoclonal antibody F(ab)2 fragment to subcutaneous human glioma xenografts using local hyperthermia
14. Effect of hyperthermia on tumor uptake of radiolabeled anti-neural cell adhesion molecule antibody in small-cell lung cancer xenografts
15. Hyperthermic modulation of radiolabeled antibody uptake in a human glioma xenograft and normal tissues
16. Combining hyperthermia and radiation: How beneficial?
17. Sensitization of low-dose-rate irradiation by nonlethal hyperthermia
18. Comparison of thermoradiosensitization in two human melanoma cell lines and one fibroblast cell line by concurrent mild hyperthermia and low-dose-rate irradiation
19. Enhanced cytotoxicity in combination of low dose-rate irradiation with hyperthermia in vitro
20. Alterations in tumor microvasculature during hyperthermia
21. Effect of local hyperthermia on blood flow and microenvironment: A review
22. Interstitial fluid pressure in solid tumors following hyperthermia: Possible correlation with therapeutic response
23. Hyperthermia-induced changes in antigen expression on human FME melanoma cells
24. The effects of hyperthermia on tumor carcinoembryonic antigen expression
25. Relationship between antigen density and immunotherapy response elicited by monoclonal antibodies against solid tumors
26. A monoclonal antibody against human colon cancers
27. Rhenium-186-mercaptoacetyltriglycine labeled monoclonal antibody for radioimmunotherapy: In vitro assessment, in vivo kinetics and dosimetry in tumor-bearing nude mice
28. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess
29. Radionuclide decay schemes and nuclear parameters for use in radiation-dose estimation
30. Radioimmunotherapy of cancer: Clinical studies and limiting factors
31. Tumour pO2 can be increased markedly by mild hyperthermia
32. Tumour oxygenation is increased by hyperthermia at mild temperatures